الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, ikke-småcellet lunge - antineoplastiske midler - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasmer, kastration-resistent - antineoplastiske midler - treatment of adult patients with prostate cancer.

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

amgros i/s - glucosemonohydrat, kaliumchlorid, natriumchlorid, natriumlactat opløsning - infusionsvæske, opløsning - 0,67+1,0+1,56+55 g/l

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

sensidose ab - carbidopamonohydrat, levodopa - dispergible tabletter til dosisdispenser - 5+1,25 mg

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning - 50 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

amgros i/s - glucosemonohydrat, kaliumchlorid - infusionsvæske, opløsning - 3,8 mg/ml+34,1 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - glucosemonohydrat, kaliumchlorid, natriumchlorid - infusionsvæske - 1,492+2,338+55 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning